Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | Executive Vice President - HR | March 02, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date March 02, 2026 · Filed March 18, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2036-03-02 | Direct | 16,926 |
Reported balance
After 2026-03-02 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-03-02 · Grant · Acquired 16,926 · Balance 16,926 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. F2: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,282 shares for a total of 16,926 RSUs granted. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
F2: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,282 shares for a total of 16,926 RSUs granted.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 4, 2026 21:01 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 10,999 | $0.00 Strike: $45.79 | $0.00 |
DisclosureSEC source: 0000816956-26-000025 · form4.xml · derivative · entry 2 Ferrell John D. · CIK 0001980620 · Executive Vice President - HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,999 Underlying: Common Stock · 10,999 shares Expires 2036-03-02 F2 · derivative.exercise_date: The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:01 UTC | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 9,282 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000025 · form4.xml · derivative · entry 1 Ferrell John D. · CIK 0001980620 · Executive Vice President - HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,282 Underlying: Common Stock · 9,282 shares Expires 2036-03-02 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. Read SEC document |
| March 02, 2026 Filed Mar 18, 2026 17:55 UTC Amendment | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 16,926 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000033 · form4a.xml · derivative · entry 1 Ferrell John D. · CIK 0001980620 · Executive Vice President - HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,926 Underlying: Common Stock · 16,926 shares Expires 2036-03-02 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. F2 · derivative.underlying_shares: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,282 shares for a total of 16,926 RSUs granted. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 20:45 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 21,516 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001127602-25-008271 · form4.xml · derivative · entry 1 Ferrell John D. · CIK 0001980620 · Executive Vice President - HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,516 Underlying: Common Stock · 21,516 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:13 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 11,250 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008512 · form4.xml · derivative · entry 1 Ferrell John D. · CIK 0001980620 · Executive Vice President - HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:39 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,700 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-23-018440 · form4.xml · derivative · entry 3 Ferrell John D. · CIK 0001980620 · Executive Vice President - HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,700 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:39 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,700 | $131.81 | $224,077.00 |
DisclosureSEC source: 0001127602-23-018440 · form4.xml · nonDerivative · entry 2 Ferrell John D. · CIK 0001980620 · Executive Vice President - HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 702 Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:39 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,700 | $41.93 | $71,281.00 |
DisclosureSEC source: 0001127602-23-018440 · form4.xml · nonDerivative · entry 1 Ferrell John D. · CIK 0001980620 · Executive Vice President - HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.